RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 125 filers reported holding RELAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,907 | -39.6% | 89,763 | -9.7% | 0.00% | -50.0% |
| Q2 2023 | $1,249,029 | -24.7% | 99,445 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,658,562 | +8.9% | 100,702 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $1,523,492 | -30.1% | 101,974 | +4.8% | 0.00% | -50.0% |
| Q3 2022 | $2,178,000 | +47.7% | 97,342 | +10.6% | 0.00% | +100.0% |
| Q2 2022 | $1,475,000 | -26.2% | 88,031 | +31.9% | 0.00% | -33.3% |
| Q1 2022 | $1,998,000 | -12.0% | 66,758 | -9.7% | 0.00% | 0.0% |
| Q4 2021 | $2,270,000 | +22.4% | 73,904 | +25.6% | 0.00% | +50.0% |
| Q3 2021 | $1,855,000 | -37.2% | 58,843 | -27.1% | 0.00% | -50.0% |
| Q2 2021 | $2,953,000 | +23.5% | 80,693 | +16.7% | 0.00% | +33.3% |
| Q1 2021 | $2,391,000 | +18.1% | 69,165 | +42.0% | 0.00% | 0.0% |
| Q4 2020 | $2,024,000 | -2.4% | 48,708 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,074,000 | – | 48,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,130,605 | $96,141,000 | 3.49% |
| Casdin Capital, LLC | 3,857,253 | $118,456,000 | 3.34% |
| Grace Capital | 183,112 | $5,623,000 | 3.34% |
| Boxer Capital, LLC | 2,669,132 | $81,969,000 | 3.18% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $856,961,000 | 2.50% |
| Integral Health Asset Management, LLC | 225,000 | $6,910,000 | 1.91% |
| Fernwood Investment Management, LLC | 185,063 | $5,683,000 | 1.86% |
| EcoR1 Capital, LLC | 1,779,084 | $54,636,000 | 1.74% |
| HARVARD MANAGEMENT CO INC | 541,124 | $16,618,000 | 1.56% |
| Bellevue Group AG | 4,105,962 | $126,094,000 | 1.30% |